Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles

Journal of Pharmaceutical Sciences

Volumn 102, Issue 10, 2013, Pages 3614-3622

  Han, Tao ^a   Das, Diganta Bhusan ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Diffusion; Franz diffusion cell; High molecular weight drug; HPLC; Microneedles; Permeability; Skin; Sonophoresis; Transdermal drug delivery; Ultrasound

Indexed keywords

BOVINE SERUM ALBUMIN;

ARTICLE; DIFFUSION; EPIDERMIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MICRONEEDLE; MOLECULAR WEIGHT; SKIN GRAFT; SKIN PERMEABILITY; SKINFOLD THICKNESS; SONOPHORESIS; TRANSDERMAL DRUG ADMINISTRATION; ULTRASOUND;

DIFFUSION; FRANZ DIFFUSION CELL; HIGH MOLECULAR WEIGHT DRUG; HPLC; MICRONEEDLES; PERMEABILITY; SKIN; SONOPHORESIS; TRANSDERMAL DRUG DELIVERY; ULTRASOUND;

ADMINISTRATION, CUTANEOUS; ANIMALS; CATTLE; DRUG DELIVERY SYSTEMS; EAR; NEEDLES; PERMEABILITY; SERUM ALBUMIN, BOVINE; SKIN; SKIN ABSORPTION; SWINE; ULTRASONICS;

EID: 84883791295     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23662     Document Type: Article

References (45)

1. Hillery AM, Lloyd AW, Swarbrick J. 2001. Drug delivery and targeting for pharmacists and pharmaceutical scientists. New York City, New York: CRC.
2. Schaefer H. 1996. Skin barrier: Principles of percutaneous absorption. Basel, Switzerland: Karger.
3. Hadgraft J, Guy RH, Eds. 1989. Transdermal drug delivery: Developmental issues and research initiatives. New York, New York: Marcel Dekker.
4. Dahlan H, Alpar HO, Murdan S. 2009. An investigation into the combination of low frequency ultrasound and liposomes on skin permeability. Int J Pharm 379(1):139-142.
5. Tachibana K. 1992. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharm Res 9(7):952-954.
6. Devin VM, Ping MW, Shawn PD. 2003. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Nat Acad Sci USA 100(24):13755-13760.
7. Dahlan A, Alpar H, Stickings P. 2009. Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm 368(1-2):123-128.
8. Barry WB. 2001. Novel mechanism and devices to enable successful transdermal delivery. Eur J Pharm Sci 14:101-114.
9. Banga AK, Prausnitz MR. 1998. Delivery of protein and gene-based drugs by skin electroporation. Trends Biotech 16:408-412.
10. Banga AK, Bose S, Ghosh TK. 1999. Iontophoresis and electroporation: Comparisons and contrasts. Int J Pharm 179:1-19.
11. Johnson ME, Berk DA, Blankschtein D, Golan DE, Jain RK, Langer RS. 1996. Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. Biophys J 71:2656-2668.
12. Barry BJ. 1987. Mode of action of penetration enhancers in human skin. J Control Release 6:85-97.
13. Olatunji O, Das DB, Nassehi V. 2012. Modelling transdermal drug delivery using microneedles: Effect of geometry on drug transport behaviour. J Pharm Sci 101(1):164-175.
14. Mitragotri S, Kost J. 2004. Low-frequency sonophoresis: A review. Adv Drug Deliv Rev 56:589-601.
15. Al-Qallaf B, Das DB. 2009. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Ann NY Acad Sci 1161:83-94.
16. Nayak A, Das DB. 2013. Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine. Biotechnol Lett.[In Press DOI: 10.1007/s10529-013-1217-3]
17. Olatunji O, Das DB, Garland MJ, Belaid L, Donnelly RF. 2013. Influence of array interspacing on the force required for successful microneedle skin penetration: Theoretical and practical approaches. J Pharm Sci 102(4):1209-1221.
18. Michael AM. 2002. Transdermal delivery of therapeutic compounds by iontophoresis. PhD Thesis. Florida: University of Florida.
19. Fellinger K, Schmidt J. 1954. Klinik and therapies des chromischen gelenkreumatismus. Maudrich Vienna, Austria: 549-552.
20. Kremkau FW. 1983. Diagnostic ultrasound: Physical principles and exercises. New York, NY: Grune & Stratton doi:10.1118/1.595274.
21. Tezel A, Sens A, Tuscherer J, Mitragotri S. 2001. Frequency dependence of sonophoresis. Pharm Res 18(12):1694-1700.
22. Macheta L, Cochelina N, Patata F, Arbeille B, Machet MC, Lorette G and Vaillant L 1998. In vitro phonophoresis of mannitol, oestradiol and hydrocortisone across human and hairless mouse skin. Int J Pharm 165(2):169-174.
23. Meidan V, Docker M, Walmsley A, Irwin W. 1998. Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption. Pharm Res 15:85-92.
24. Polat BE, Hart D, Langer R, Blankschtein D. 2011. Ultrasound mediated transdermal drug delivery: Mechanisms, scope, and emerging trends. J Control Release 152:330-348.
25. Polat BE, Hart D, Langer R, Blankschtein D. 2011. Ultrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends. J Control Release 152:330-348.
26. Gaertner W. 1954. Frequency dependence of ultrasonic cavitation. J Acoustical Soc Am 26(6):977-980.
27. Leighton TG. 1998. An introduction to acoustic cavitation. Medical Science Series. Ultrasound in medicine (Chapter 11) pp. 199-233. Bristol, UK: Institute of Physics Publishing.
28. Bommannan D, Okuyama H, Stauffer P, Guy RH. 1992. Sonophoresis: I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res 9:559-564.
29. Bommannan D, Okuyama H, Stauffer P, Guy RH. 1992. Sonophoresis: II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res 9:1043-1047.
30. Kennedy JE, Haar GHT, Cranston D. 2003. High intensity focused ultrasound: Surgery of the future? Br J Radiol 76:590-599.
31. Boucaud A, Garrigue MA, Machet L, Vaillant L and Patat F. 2002. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J Control Release 81:113-119.
32. Al-Qallaf B, Das DB. 2009. Optimizing microneedle arrays for transdermal drug delivery: Extension to non-square distribution of microneedles. J Drug Target 17(2):108-122.
33. Al-Qallaf B, Das DB, Davidson A. 2009. Transdermal drug delivery by coated microneedles: Geometry effects on drug concentration in blood. Asia-Pacific J Chem Eng 4(6):845-857.
34. Gerstel MS, Place VA. 1976. Drug delivery device. US Patent 3964482.
35. Henry S, McAllister D, Allen MG, Prausnitz MR. 1998. Microfabricated microneedles: A novel method to increase transdermal drug delivery. J Pharm Sci 87:922-925.
36. Gill HS, Denson DD, Burris BA, Prausnitz MR. 2008. Effect of microneedle design on pain in human volunteers. Clinic J Pain 24(7):585-594.
37. Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR 2004. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 21(6):947-952.
38. Haripriya K, Ajay K. 2011. Transdermal delivery of proteins. PhamSciTech 12(1):431-441.
39. Marcia S. 2011. Skin grafts-Indications, applications and current research. Winchester, UK: Intech.
40. Brown MB, Martin GP, Jones SA, Akomeah FK. 2006. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Delivery 13:175-187.
41. Kushner J. 2006. Theoretical and experimental investigations of passive and ultrasound-enhanced transdermal drug delivery. PhD Thesis. Cambridge: Massachusetts Institute of Technology.
42. Kalia YN, Guy RH. 2001. Modeling transdermal drug release. Adv Drug Deliv Rev 48:159-172.
43. Levy D, Kost J, Meshulam Y, Langer R. 1989. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clinic Invest 83:2074-2078.
44. Bangtao C, Jiashen W, Ciprian I. 2010. Sonophoretic enhanced microneedles array (SEMA)-Improving the efficiency of transdermal drug delivery. Sensors Actuators 145:54-60.
45. Devin V, Ping MW, Shawn PD, Jung HP, Paul JC, Mark GA, Mark RP 2003. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. PNAS 100(24):13755-13760.